WHWilliam L. Hamilton

William L. Hamilton

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


William L. Hamilton has a total of 532 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic performance of serum galactomannan and bronchoalveolar lavage Aspergillus PCR in febrile neutropenic haemato-oncology patients: a single-centre evaluation

    by William L Hamilton, James Moore, Poorvi Patel, Andrew King, David A Enoch

    Introduction Invasive fungal infections (IFI) are an important cause of morbidity and mortality in haemato-oncology (haem-onc) patients with neutropenia, requiring rapid and accurate diagnosis. Gap Statement With widespread use of mould-active prophylaxis, the diagnostic value of serum Aspergillus galactomannan (AGM) is uncertain; real-world data to guide cost-effective diagnostic strategies are limited. Aim To assess the diagnostic performance, clinical utility and cost-effectiveness of serum AGM compared with bronchoalveolar lavage fluid (BALF) Aspergillus PCR in neutropenic haem-onc patients. Methodology A single-centre evaluation at a large teaching hospital in the United Kingdom, including: (1) analysis of AGM testing performed in 2024; (2) clinical audit of neutropenic fever management in adult haem-onc patients; (3) laboratory verification of a commercial Aspergillus PCR assay; and (4) cost-benefit analysis of IFI diagnostic pathways. Results Among 1,187 AGM tests (860 serum; 327 BALF) performed in 2024, overall positivity was 3.1%. Serum AGM positivity was 1.0% overall and 99% cases, would offset the cost of introducing Aspergillus PCR for all BALF samples. Conclusion Serum AGM has limited clinical value in prophylaxed neutropenic haem-onc patients, while CT imaging is essential. Incorporating BALF Aspergillus PCR while reducing serum AGM testing in neutropenic haem-onc patients could improve diagnostic pathways and deliver cost savings.

  • Open Access

    Associations between the Plasmodium falciparum genome and sickle haemoglobin identified in mild malaria cases from Ghana

    by William L. Hamilton, Annie J. Forster, Yaw Aniweh, Victor Asoala, Eleanor Drury, Kirk A. Rockett, Gordon A. Awandare, Dominic P. Kwiatkowski, Gavin Band, Lucas N. Amenga-Etego

    Background: Heterozygosity for sickle haemoglobin (HbS) confers protection against severe malaria caused by the parasite Plasmodium falciparum. Recent work has suggested that this protective effect can depend on the parasite genotype: P. falciparum sickle-associated ( Pfsa ) variants were found disproportionately in individuals with severe malaria carrying HbS alleles in The Gambia and Kenya. Interactions between the P. falciparum genome and HbS have not previously been investigated in mild malaria cases or in Ghana. Methods: We performed a genome-wide association analysis of P. falciparum against human β-globin genotypes in a sample of 1,368 people with mild malaria in northern Ghana. Results: We replicated the previously identified associations with HbS at two parasite loci ( Pfsa1 and Pfsa3 ). Pfsa2 was absent from this population. A candidate newly identified locus within the serine/ threonine kinase FIKK4.2 , which we putatively term Pfsa4 , was also associated with HbS; this finding replicated in a published sample from Mali. The Pfsa1-4 mutations vary widely in frequencies across Africa, are absent or very low frequency in Asia, and are highly correlated with each-other across multiple populations. We found no strong associations with haemoglobin C. Conclusions: This study replicates previously reported sickle-associated loci in the P. falciparum genome and has produced new evidence of a potential association with sickle haemoglobin at a fourth parasite locus. Further research is needed to validate the tentative fourth locus. These findings add new complexity to the emerging picture of association between human and co-evolving malaria parasite genomes, suggesting new avenues for functional exploration.


  • Open Access

    De novo assembly of complete Plasmodium falciparum isolate genomes using PacBio HiFi sequencing technology

    by Prince B. Nyarko, Mathieu Quenu, Marc-Antoine Guery, Camille Cohen, Godfrey Kinyori Wagutu, William L. Hamilton, Sophia T. Girgis, Alex Makunin, Shane A. McCarthy, Mara K. N. Lawniczak, et al.

    Plasmodium falciparum possesses a highly structured genome with extensive sequence diversity concentrated in Variant Surface Antigen (VSA) families. These genes— var , rif , and stevor —play key roles in immune evasion and pathogenesis and are difficult to assemble using short-read sequencing technologies. Here, we applied PacBio HiFi long-read sequencing to generate high-quality de novo genome assemblies from 43 P. falciparum parasite cultures originating from community cases in The Gambia. Parasites were culture-adapted, cloned by limiting dilution where possible, and sequenced using high molecular weight DNA extracts. Assemblies from single-genotype lineages were constructed using hifiasm, producing complete chromosomal-length scaffolds with high base accuracy without requiring short-read polishing. We recovered full repertoires of var , rif , and stevor genes and classified them into known subgroups. Together, our results demonstrate that PacBio HiFi sequencing enables accurate assembly of complex P. falciparum genomes from natural infections. This work provides a valuable genomic resource for future studies of parasite evolution, transmission dynamics, and antigenic diversity, and suggests that VSA repertoires can serve as reliable proxies of genetic relatedness across infections.


  • Open Access

    Associations between sickle haemoglobin and the Plasmodium falciparum CLAG and FIKK gene families revealed by meta-analysis of 6,289 African samples

    by Annie J. Forster, James Docker, Katie Healey, Zhipeng Zhang, Amy Trebes, David Buck, William L. Hamilton, Lucas Amenga-Etego, Alexander J. Mentzer, Alfred Amambua-Ngwa, et al.

    The recent discovery that mutations in the Plasmodium falciparum genome are overrepresented in infections of sickle haemoglobin (HbS)-carriers has highlighted new questions about the underlying biological and evolutionary interaction, yet the full extent of this association is unknown. By meta-analysing host and parasite data from N=6,289 infections, including 831 newly sequenced samples from The Gambia, we implicate several new parasite genome regions in the interaction, including within the CLAG3 nutrient uptake channel and the threonine/serine kinase FIKK3 on chromosome 3. The HbS-associated mutations share unusually strong linkage disequilibrium, and we use a series of analyses to disentangle their complex genetic structure and independent effects. The most prominent signal is observed at a polymorphism shared between two CLAG3 paralogs, estimated to halve the level of protection due to HbS. Alongside previous findings in ACS8 and FIKK4 . 2 , these results now implicate three of the major P. falciparum gene families in host-parasite interactions and open new avenues for functional inquiry.

  • Open Access

    The changing landscape of HIV epidemiology and management

    by William L. Hamilton, Sani H. Aliyu


  • Open Access

    An expanded method for malaria parasite genetic surveillance using targeted nanopore sequencing

    by Alexandria J. R. Harrott, Collins M. Morang'A, Richard D. Pearson, Mona-Liza Sakyi, Ahmed Osumanu, Enock K. Amoako, Fagdéba David Bara, Myra Hosmillo, Kess Rowe, Yaw Aniweh, et al.

    Malaria causes around 250 million cases and over 600,000 deaths annually, with the heaviest burden falling on young children living in sub-Saharan Africa. Molecular surveillance of Plasmodium parasites and Anopheles mosquito vectors are key components of effective malaria control decision-making. Previously, we have designed and implemented a nanopore-based workflow for targeted P. falciparum molecular surveillance in Ghana, which we call DRAG1 (drug resistance + antigen multiplex PCR). Here, we describe an updated and expanded multiplex assay (‘DRAG2’) with additional amplicon targets that incorporate more antimalarial drug resistance markers, the polymorphic surface antigen merozoite surface protein 2 (msp2), and the 18S ribosomal RNA (rRNA) gene for Plasmodium species detection. We describe the performance of the DRAG2 assay over a range of parasitaemias and sample types (venous blood and dried blood spots), with suggested systems of quality control including the use of synthetic plasmids for positive controls and recommended coverage thresholds. The plasmids are highly economical, and engineered to include both ‘test’ single nucleotide polymorphisms (SNPs), such as known drug resistance markers, and ‘control’ SNPs, which are not found in nature and thus signal contamination if detected in clinical samples. We provide standard operating procedures (SOPs) for use by teams aiming to implement the assay in their laboratory. In summary, we describe an updated nanopore-based method for malaria molecular surveillance, including detailed consideration of quality control processes and SOPs. These are important steps in the transition from research tool to diagnostic assay, which will require further testing in endemic settings and regulatory processes and approvals.


  • Open Access

    Variable rates of SARS-CoV-2 evolution in chronic infections

    by Ewan Smith, William L Hamilton, Ben Warne, Elena R Walker, Aminu S Jahun, Myra Hosmillo, ISARIC Consortium, Ravindra K Gupta, Ian Goodfellow, Effrossyni Gkrania-Klotsas, et al.

    An important feature of the evolution of the SARS-CoV-2 virus has been the emergence of highly mutated novel variants, which are characterised by the gain of multiple mutations relative to viruses circulating in the general global population. Cases of chronic viral infection have been suggested as an explanation for this phenomenon, whereby an extended period of infection, with an increased rate of evolution, creates viruses with substantial genetic novelty. However, measuring a rate of evolution during chronic infection is made more difficult by the potential existence of compartmentalisation in the viral population, whereby the viruses in a host form distinct subpopulations. We here describe and apply a novel statistical method to study within-host virus evolution, identifying the minimum number of subpopulations required to explain sequence data observed from cases of chronic infection, and inferring rates for within-host viral evolution. Across nine cases of chronic SARS-CoV-2 infection in hospitalised patients we find that non-trivial population structure is relatively common, with four cases showing evidence of more than one viral population evolving independently within the host. We find cases of within-host evolution proceeding significantly faster, and significantly slower, than that of the global SARS-CoV-2 population, and of cases in which viral subpopulations in the same host have statistically distinguishable rates of evolution. Non-trivial population structure was associated with high rates of within-host evolution that were systematically underestimated by a more standard inference method.


  • Open Access

    A complex Plasmodium falciparum cryptotype circulating at low frequency across the African continent

    by Olivo Miotto, Alfred Amambua-Ngwa, Lucas Amenga-Etego, Muzamil M Abdel Hamid, Ishag Adam, Enoch Aninagyei, Tobias Apinjoh, Gordon A Awandare, Philip Bejon, Gwladys I Bertin, et al.

    The population structure of the malaria parasite Plasmodium falciparum can reveal underlying demographic and adaptive evolutionary processes. Here, we analyse population structure in 4,376 P. falciparum genomes from 21 countries across Africa. We identified a strongly differentiated cluster of parasites, comprising ∼1.2% of samples analysed, geographically distributed over 13 countries across the continent. Members of this cluster, named AF1, carry a genetic background consisting of a large number of highly differentiated variants, rarely observed outside this cluster, at a multitude of genomic loci distributed across most chromosomes. At these loci, the AF1 haplotypes appear to have common ancestry, irrespective of the sampling location; outside the shared loci, however, AF1 members are genetically similar to their sympatric parasites. AF1 parasites sharing up to 23 genomic co-inherited regions were found in all major regions of Africa, at locations over 7,000 km apart. We coined the term cryptotype to describe a complex common background which is geographically widespread, but concealed by genomic regions of local origin. Most AF1 differentiated variants are functionally related, comprising structural variations and single nucleotide polymorphisms in components of the MSP1 complex and several other genes involved in interactions with red blood cells, including invasion and erythrocyte antigen export. We propose that AF1 parasites have adapted to some as yet unidentified evolutionary niche, by acquiring a complex compendium of interacting variants that rarely circulate separately in Africa. As the cryptotype spread across the continent, it appears to have been maintained mostly intact in spite of recombination events, suggesting a selective advantage. It is possible that other cryptotypes circulate in Africa, and new analysis methods may be needed to identify them.


  • Open Access

    Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana

    by Sophia T. Girgis, Edem Adika, Felix E. Nenyewodey, Dodzi K. Senoo Jnr, Joyce M. Ngoi, Kukua Bandoh, Oliver Lorenz, Guus van de Steeg, Alexandria J. R. Harrott, Sebastian Nsoh, et al.

    Malaria results in over 600,000 deaths annually, with the highest burden of deaths in young children living in sub-Saharan Africa. Molecular surveillance can provide important information for malaria control policies, including detection of antimalarial drug resistance. However, genome sequencing capacity in malaria-endemic countries is limited. We designed and implemented an end-to-end workflow to detect Plasmodium falciparum antimalarial resistance markers and diversity in the vaccine target circumsporozoite protein (csp) using nanopore sequencing in Ghana. We analysed 196 clinical samples and showed that our method is rapid, robust, accurate and straightforward to implement. Importantly, our method could be applied to dried blood spot samples, which are readily collected in endemic settings. We report that P. falciparum parasites in Ghana are mostly susceptible to chloroquine, with persistent sulfadoxine-pyrimethamine resistance and no evidence of artemisinin resistance. Multiple single nucleotide polymorphisms were identified in csp, but their significance is uncertain. Our study demonstrates the feasibility of nanopore sequencing for malaria genomic surveillance in endemic countries.


  • Open Access

    The clinical, genomic, and microbiological profile of invasive multi-drug resistant Escherichia coli in a major teaching hospital in the United Kingdom

    by William L. Hamilton, Suny Coscione, Mailis Maes, Ben Warne, Lindsay J. Pike, Fahad A. Khokhar, Beth Blane, Nicholas M. Brown, Theodore Gouliouris, Gordon Dougan, et al.

    Escherichia coli is a ubiquitous component of the human gut microbiome, but is also a common pathogen, causing around 40, 000 bloodstream infections (BSI) in the United Kingdom (UK) annually. The number of E. coli BSI has increased over the last decade in the UK, and emerging antimicrobial resistance (AMR) profiles threaten treatment options. Here, we combined clinical, epidemiological, and whole genome sequencing data with high content imaging to characterise over 300 E. coli isolates associated with BSI in a large teaching hospital in the East of England. Overall, only a limited number of sequence types (ST) were responsible for the majority of organisms causing invasive disease. The most abundant (20 % of all isolates) was ST131, of which around 90 % comprised the pandemic O25b:H4 group. ST131-O25b:H4 isolates were frequently multi-drug resistant (MDR), with a high prevalence of extended spectrum β-lactamases (ESBL) and fluoroquinolone resistance. There was no association between AMR phenotypes and the source of E. coli bacteraemia or whether the infection was healthcare-associated. Several clusters of ST131 were genetically similar, potentially suggesting a shared transmission network. However, there was no clear epidemiological associations between these cases, and they included organisms from both healthcare-associated and non-healthcare-associated origins. The majority of ST131 isolates exhibited strong binding with an anti-O25b antibody, raising the possibility of developing rapid diagnostics targeting this pathogen. In summary, our data suggest that a restricted set of MDR E. coli populations can be maintained and spread across both community and healthcare settings in this location, contributing disproportionately to invasive disease and AMR.